![Robin Evers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robin Evers
Direktor/Vorstandsmitglied bei
OREXO AB
Vermögen: 17 136 $ am 31.05.2026
Profil
Robin Evers is currently an Independent Director at Orexo AB since 2023 and Senior VP & Head-Global Regulatory Affairs at Novo Nordisk A since 2024.
Former roles include Head-Global Regulatory Affairs & Vice President at Wyeth Pharmaceuticals, Inc. from 2007 to 2010 and Vice President-Worldwide Safety & Regulatory at Pfizer Inc. from 2010 to 2013.
Education includes undergraduate degrees from the University of Portsmouth and the University of Reading.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OREXO AB 0.02% | 31.12.2025 | 7’718 ( 0.02% ) | 17 136 $ | 31.05.2026 |
Aktive Positionen von Robin Evers
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVO NORDISK A/S | General Counsel | 01.03.2024 |
| OREXO AB | Direktor/Vorstandsmitglied | 27.10.2023 |
Ehemalige bekannte Positionen von Robin Evers
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.11.2013 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | General Counsel | 01.01.2010 |
Ausbildung von Robin Evers
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Wählen Sie MarketScreener 
